VaIN2
5 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years (NCT04895020) | Shanghai Bovax Biotechnology Co., Ltd. | 2021-05-28 |
| Evaluate the Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females (NCT05372016) | Shanghai Bovax Biotechnology Co., Ltd. | 2020-09-19 |
| Evaluate the Immunogenicity and Safety of 4-valent and 9-valent HPV Recombinant Vaccine in Chinese Healthy Females (NCT04425291) | Shanghai Bovax Biotechnology Co., Ltd. | 2020-05-28 |
| Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females (NCT04422366) | Shanghai Bovax Biotechnology Co., Ltd. | 2020-04-28 |
| Evaluate the Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females (NCT03676101) | Shanghai Bovax Biotechnology Co., Ltd. | 2018-10-10 |
Track VaIN2 automatically
Every clearance here is in the API, with alerts when new ones post.